Pfizer to manage holdings as small units

NEW YORK Drug maker Pfizer will manage its holdings as small units in a similar fashion to Johnson & Johnson, CEO Jeffrey Kindler told Bloomberg.

Kindler told the news agency that following Pfizer's acquisition of Wyeth, which caused the world's biggest drug maker to grow by 50%, he is dividing it into separate units to manage various product divisions, which include prescription drugs, OTC drugs, vitamins and vaccines.